Prescribing of NICE-recommended tablets for endometriosis and fibroids has more than tripled in a year across England, giving thousands of additional women another option to manage painful and debilitating symptoms.
Innovative AI technologies have the potential to act like a ‘second pair of eyes’, helping radiologists review prostate MRI scans.
Around 1,000 people with HER2-low advanced breast cancer can now be offered Enhertu after NICE recommended it for routine NHS use.
People with obsessive-compulsive disorder (OCD) and body dysmorphic disorder (BDD) could be identified earlier and offered more appropriate treatment under draft NICE guidance published today.
Sepsis caused 133,484 hospital admissions in England in 2024/25, and can be fatal within hours if not treated promptly. A new Modern Service Framework aims to change that, with NICE evidence shaping how the NHS identifies and treats sepsis more consistently.
Our annual report and accounts covering April 2025 to March 2026 highlight our key achievements. Find out how we’re delivering against the 10 Year Health plan, and how we’re becoming more relevant, timely, impactful and usable.
Evidence in one place: how NICE’s women’s health topic suite supports the government’s women’s health strategy.
From blood-based biomarkers to AI-powered tools, discover how 9 innovations are being tested in the NHS to speed up dementia diagnosis.
